Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.62 |
| ▸ | CES1 | P23141 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.45 |
| ▸ | FEN1 | P39748 | 1/20 | 0.45 |
| ▸ | FLT1 | P17948 | 1/20 | 0.42 |
| ▸ | FLT4 | P35916 | 1/20 | 0.42 |
| ▸ | KDR | P35968 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL374630 | 0.84 | ALDH1A1 (0.56) | CES2CES1ALDH1A1POLBTSHR | |
| SCHEMBL33952 | 0.84 | ALDH1A1 (0.56) | CES2CES1ALDH1A1POLBTSHR | |
| SCHEMBL4077898 | 0.80 | SMN1; SMN2 (0.54) | CES2CES1POLBTSHRLMNA | |
| SCHEMBL1821100 | 0.79 | CES2 (0.59) | CES2CES1ALDH1A1POLBTSHR | |
| SCHEMBL3138767 | 0.78 | CES2 (0.54) | CES2CES1ALDH1A1POLBTSHR | |
| SCHEMBL50416 | 0.77 | CES2 (0.71) | CES2CES1ALDH1A1POLBTSHR | |
| SCHEMBL9989507 | 0.77 | CES2 (0.56) | CES2CES1ALDH1A1POLBTSHR | |
| SCHEMBL5408652 | 0.77 | CES2 (0.56) | CES2CES1ALDH1A1POLBTSHR | |
| SCHEMBL6317444 | 0.77 | CES2 (1.00) | CES2CES1ALDH1A1POLBTSHR | |
| SCHEMBL1431970 | 0.77 | CES2 (0.56) | CES2CES1ALDH1A1POLBTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113861099-B | Free radical initiator, luminescent free radical polymer and preparation method thereof | 香港中文大学（深圳） | 2023-04-28 | — | — | CN | claimed |
| CN-113861099-B | Free radical initiator, luminescent free radical polymer and preparation method thereof | 香港中文大学（深圳） | 2023-04-28 | — | — | CN | disclosed |
| CN-113861099-A | Free radical initiator, luminescent free radical polymer and preparation method thereof | 香港中文大学（深圳） | 2021-12-31 | — | — | CN | disclosed |
| US-9233922-B2 | Process for producing N-(hetero)arylazoles | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-01-12 | — | — | US | disclosed |
| EP-2736881-B1 | PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES | TAKASAGO PERFUMERY CO LTD (JP) | 2015-10-07 | — | — | EP | disclosed |
| US-20140371461-A1 | PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2014-12-18 | — | — | US | disclosed |
| EP-2736881-A1 | PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES | Takasago International Corporation (JP) | 2014-06-04 | — | — | EP | disclosed |
| WO-2013032035-A1 | PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-03-07 | — | — | WO | disclosed |
| EP-2048170-A2 | Second catalyst component for addition polymerization, catalyst for addition polymerization, and process for producing addition polymer | Sumitomo Chemical Company, Limited (JP) | 2009-04-15 | — | — | EP | disclosed |
| EP-2048168-A2 | Process for producing catalyst component for addition polymerization, catalyst for addition polymerization, and process for producing addition polymer | Sumitomo Chemical Company, Limited (JP) | 2009-04-15 | — | — | EP | disclosed |
| EP-2048167-A2 | First catalyst component for addition polymerization, catalyst for addition polymerization, and process for producing addition polymer | Sumitomo Chemical Company, Limited (JP) | 2009-04-15 | — | — | EP | disclosed |
| EP-2048169-A2 | Third catalyst component for addition polymerization, catalyst for addition polymerization, and process for producing addition polymer | Sumitomo Chemical Company, Limited (JP) | 2009-04-15 | — | — | EP | disclosed |
| US-6914108-B2 | Catalyst component for addition polymerization, catalyst for addition polymerization, and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-07-05 | — | — | US | disclosed |
| US-20030203810-A1 | Catalyst component for addition polymerization, catalyst for addition polymerization, and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED | 2003-10-30 | — | — | US | disclosed |
| US-6586356-B2 | Coordination catalyst | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-07-01 | — | — | US | disclosed |
| WO-2002100885-A2 | A PENTA- OR TETRAPEPTIDE BINDING TO SOMATOSTATIN RECEPTORS AND THE USE OF THE SAME | NOVASPIN BIOTECH GMBH (DE) | 2002-12-19 | — | — | WO | disclosed |
| US-20010020075-A1 | Catalyst component for addition polymerization, catalyst for addition polymerization, and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-09-06 | — | — | US | disclosed |
| EP-1113026-A2 | Catalyst component for addition polymerization, catalyst for addition polymerization, and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-07-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140371461-A1 | PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES | CYP3A4, HCN4, PPOX | CES2 4192/4885CES1 4430/4885ALDH1A1 3167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.